Marta
Llanos Muñoz
Profesora Asociada Asistencial
Hospital Universitario Puerta de Hierro
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (19)
2023
-
A genetic profiling guideline to support diagnosis and clinical management of lymphomas
Clinical and Translational Oncology
-
Monitoring of Circulating Tumor DNA Predicts Response to Treatment and Early Progression in Follicular Lymphoma: Results of a Prospective Pilot Study
Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 29, Núm. 1, pp. 209-220
-
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2749-2758
2022
-
Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study
European Thyroid Journal, Vol. 11, Núm. 5
2021
-
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
Scientific Reports, Vol. 11, Núm. 1
2019
-
Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years
Leukemia and Lymphoma
-
Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group
Leukemia and Lymphoma
-
Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group
Hematological Oncology, Vol. 37, Núm. 2, pp. 143-150
-
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma
PLoS ONE, Vol. 14, Núm. 2
2017
-
Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group
Clinical Lymphoma, Myeloma and Leukemia, Vol. 17, Núm. 3, pp. 186-191
2015
-
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
Cancer and Metastasis Reviews, Vol. 34, Núm. 3, pp. 381-400
-
SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1005-1013
-
SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma
Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1014-1019
2014
-
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: A multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group
Leukemia and Lymphoma, Vol. 55, Núm. 1, pp. 51-55
-
High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma
Leukemia and Lymphoma
-
Risk adapted high-dose and dose-dense therapies modulate the impact of biological classification in diffuse large B-cell lymphoma prognosis
Haematologica
2012
-
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
Clinical and Translational Oncology, Vol. 14, Núm. 5, pp. 386-390
2010
-
SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma
Clinical and Translational Oncology, Vol. 12, Núm. 11, pp. 760-764
2008
-
R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: A multicentre, prospective study
Hematological Oncology, Vol. 26, Núm. 1, pp. 27-32